Primary Citation PubMed: 23058106
Citations in PubMed
This linkout lists citations, indexed by PubMed, to the Primary Citation for this PDB ID.
Data mentions are occurrences of PDB IDs in the full text articles from the
PubMedCentral Open Access Subset
of currently about 1 million articles. For each article, the sentences containing the PDB ID are listed.
Article titles can be filtered by keywords and sorted by year.
Fragment-based screening maps inhibitor interactions in the ATP-binding site of checkpoint kinase 2.
(2013) PLoS One 8
PubMed: 23776527 | PubMedCentral: PMC3680490 | DOI: 10.1371/journal.pone.0065689
(B) Superposition of the quinoxaline fragment compound 13 (light-blue), compound 22 (yellow) and the arylbenzimidazole CHK2 inhibitor 26 (pink, PDB ID code 4A9R), showing the fragments bind in a nearl... identical manner with their respective furan and p -methoxyphenyl group binding in a hydrophobic pocket above the hinge, which is also accessed by the chlorophenyl group of the CHK2 inhibitor 26 .
Publication Year: 2013
Benzimidazole inhibitors of the protein kinase CHK2: clarification of the binding mode by flexible side chain docking and protein-ligand crystallography.
(2012) Bioorg Med Chem 20
PubMed: 23058106 | PubMedCentral: PMC3778940 | DOI: 10.1016/j.bmc.2012.09.024
4.10 Accession codes Atomic coordinates and structure factors for the crystal structures of ligand-bound CHK2 can be accessed using the following PDB codes: 19 , 4A9S ; 30 , 4A9R ; 44 , 4A9T and 47 , ... A9U .
Publication Year: 2012
RCSB PDB (citation) is managed by two members of the Research Collaboratory for Structural Bioinformatics: Rutgers and UCSD/SDSC
RCSB PDB is a member of the
The RCSB PDB is funded by a grant (DBI-1338415) from the
National Science Foundation, the
National Institutes of Health, and the
US Department of Energy.